Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

Messalli, G; Imbriaco, M; Avitabile, G; Russo, R; Iodice, D; Spinelli, L; Dellegrottaglie, S; Cademartiri, F; Salvatore, M; Pisani, A

Messalli, G; Imbriaco, M; Avitabile, G; Russo, R; Iodice, D; Spinelli, L; Dellegrottaglie, S; Cademartiri, F; Salvatore, M; Pisani, A.

Affiliation

Messalli G; Dipartimento di Scienze Biomorfologiche e Funzionali, Università degli Studi Federico II, Napoli, Italy.

Radiol Med ; 117(1): 19-28, 2012 Feb.

Article in En, It | MEDLINE | ID: mdl-21744250

Subject(s)

Enzyme Replacement Therapy/methods; Fabry Disease/drug therapy; Fabry Disease/physiopathology; Heart Diseases/diagnosis; Heart Diseases/physiopathology; Isoenzymes/therapeutic use; Magnetic Resonance Imaging, Cine/methods; alpha-Galactosidase/therapeutic use; Adult; Female; Humans; Male; Risk Factors; Vectorcardiography

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fabry Disease / Alpha-Galactosidase / Magnetic Resonance Imaging, Cine / Enzyme Replacement Therapy / Heart Diseases / Isoenzymes Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En / It Journal: Radiol Med Year: 2012 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google